Skip to main content

Table 2 Definition of clinical endpoints analyzed in this study

From: Comparison of RNA-seq and microarray-based models for clinical endpoint prediction

Cohort Endpoint (bin 1/0) Training set Validation set
# Samples 1 0 # Samples 1 0
All patients (498) SEX 249 103 146 249 108 141
(Female/Male)
EFS ALL 249 89 160 249 94 155
(Event yes/no)
OS ALL 249 51 198 249 54 195
(Death yes/no)
Class labeled patients (272) CLASS LABEL 136 45 91 136 46 90
(Unfavorable/Favorable)
High-risk patients (176) EFS HR 86 55 31 90 65 25
(Event yes/no)
OS HR 86 43 43 90 49 41
(Death yes/no)
  1. EFS, event-free survival; HR, high risk; OS, overall survival